SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma

Published:2021-03-29 Issue:1 Volume:43 Page:209-219
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Zhang Xi,Duan Yu-ting,Wang Yi,Zhao Xing-dong,Sun Yi-ming,Lin Dong-ze,Chen Yi,Wang Yu-xiang,Zhou Zu-wen,Liu Yan-xin,Jiang Li-hua,Geng Mei-yu,Ding Jian,Meng Ling-hua

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-021-00644-1.pdf

Reference40 articles.

1. Miao Y, Medeiros LJ, Li Y, Li J, Young KH. Genetic alterations and their clinical implications in DLBCL. Nat Rev Clin Oncol. 2019;16:634–52.

2. Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11:12–23.

3. Coiffier B, Sarkozy C. Diffuse large B-cell lymphoma: R-CHOP failure-what to do? Hematol Am Soc Hematol Educ Program. 2016;2016:366–78.

4. Bojarczuk K, Bobrowicz M, Dwojak M, Miazek N, Zapala P, Bunes A, et al. B-cell receptor signaling in the pathogenesis of lymphoid malignancies. Blood Cells Mol Dis. 2015;55:255–65.

5. Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605–35.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma;Medical Oncology;2024-07-29

2. TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas;Life Sciences;2024-06

3. Advances in proteomics in diffuse large B‑cell lymphoma (Review);Oncology Reports;2024-05-09

4. Coumarin Derivatives from Hydrangea macrophylla and Evaluation of Their Cytotoxic Activity;Chemistry Africa;2023-03-03

5. Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles;Molecules;2023-03-01